HomeCompareSRSA vs DVY

SRSA vs DVY: Dividend Comparison 2026

SRSA yields 19.90% · DVY yields 3.50%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SRSA wins by $47.5K in total portfolio value
10 years
SRSA
SRSA
● Live price
19.90%
Share price
$10.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$72.6K
Annual income
$6,667.68
Full SRSA calculator →
DVY
DVY
● Live price
3.50%
Share price
$150.03
Annual div
$5.25
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.1K
Annual income
$437.78
Full DVY calculator →

Portfolio growth — SRSA vs DVY

📍 SRSA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSRSADVY
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SRSA + DVY cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SRSA pays
DVY pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SRSA
Annual income on $10K today (after 15% tax)
$1,691.54/yr
After 10yr DRIP, annual income (after tax)
$5,667.53/yr
DVY
Annual income on $10K today (after 15% tax)
$297.17/yr
After 10yr DRIP, annual income (after tax)
$372.11/yr
At 15% tax rate, SRSA beats the other by $5,295.42/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SRSA + DVY for your $10,000?

SRSA: 50%DVY: 50%
100% DVY50/50100% SRSA
Portfolio after 10yr
$48.8K
Annual income
$3,552.73/yr
Blended yield
7.28%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SRSA buys
0
DVY buys
0
No recent congressional trades found for SRSA or DVY in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSRSADVY
Forward yield19.90%3.50%
Annual dividend / share$2.00$5.25
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$72.6K$25.1K
Annual income after 10y$6,667.68$437.78
Total dividends collected$41.2K$4.0K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: SRSA vs DVY ($10,000, DRIP)

YearSRSA PortfolioSRSA Income/yrDVY PortfolioDVY Income/yrGap
1← crossover$12,690$1,990.05$11,050$349.62+$1.6KSRSA
2$15,939$2,360.17$12,184$361.04+$3.8KSRSA
3$19,825$2,770.41$13,409$372.07+$6.4KSRSA
4$24,433$3,220.46$14,730$382.68+$9.7KSRSA
5$29,853$3,709.39$16,154$392.89+$13.7KSRSA
6$36,178$4,235.71$17,688$402.69+$18.5KSRSA
7$43,508$4,797.38$19,338$412.07+$24.2KSRSA
8$51,945$5,391.92$21,113$421.04+$30.8KSRSA
9$61,598$6,016.43$23,020$429.61+$38.6KSRSA
10$72,577$6,667.68$25,070$437.78+$47.5KSRSA

SRSA vs DVY: Complete Analysis 2026

SRSAStock

Sarissa Capital Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify and acquire a business, which focuses on the healthcare and biopharmaceutical industry. Sarissa Capital Acquisition Corp. was incorporated in 2020 and is based in Greenwich, Connecticut.

Full SRSA Calculator →

DVYETF

The iShares Select Dividend ETF seeks to track the investment results of an index composed of relatively high dividend paying U.S. equities.

Full DVY Calculator →
📬

Get this SRSA vs DVY comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SRSA vs SCHDSRSA vs JEPISRSA vs OSRSA vs KOSRSA vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.